Markets:

Overview

News

Currencies

International

Treasuries

Curaleaf Hldgs Inc (OP:CURLF)

3.291 -0.099 (-2.92%)

Streaming Delayed Price Updated: 3:17 PM EDT, May 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Curaleaf Hldgs Inc

< Previous 1 2 3 4 5 6 7 8 9

...

56 57 Next >

Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil ↗

December 06, 2024

While dried flower exports have flourished, the growth of Canada's cannabis extracts, including oils and vapes, has been more erratic.

Via Benzinga

Topics Cannabis

Illinois Cannabis Sales Back On Track In October Hitting $142.3M After Slight September Dip ↗

December 06, 2024

ollowing a drop in September cannabis sales numbers in Illinois, October figures totaled $142.3 million, a 4.2% increase sequentially, reported New Cannabis Ventures' Alan Brochstein. Cannabis sales...

Via Benzinga

Topics Cannabis

Ho-Ho-Holy Smokes! Record Weed Sales Drive Dispensaries To Stock Smart This Holiday Season ↗

December 05, 2024

Flower remained the top-selling form factor, accounting for 43% of total sales, followed by vape at 28%, and edibles.

Via Benzinga

Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold? ↗

December 05, 2024

In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in.

Via Benzinga

Topics Cannabis

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat? ↗

December 04, 2024

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

Via Benzinga

Topics Cannabis

Grön Launches New Edibles Flavors Across Curaleaf Dispensaries In Arizona ↗

December 03, 2024

Via Benzinga

Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock? ↗

December 03, 2024

Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects.

Via Benzinga

Topics Cannabis

Cannabis Cuts Opioid Prescriptions By 53%, Utah Study Suggests ↗

December 02, 2024

Discover how cannabis for pain management reduced opioid prescriptions by 53% in Utah, signaling new opportunities for medical markets.

Via Benzinga

Topics Cannabis

Cannabis Stock Gainers And Losers From November 29, 2024 ↗

November 29, 2024

Via Benzinga

Topics Cannabis

Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA? ↗

November 28, 2024

As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.

Via Benzinga

Topics Cannabis

Flora Growth Taps Europe's CBD Boom With $500K Czech-Slovak Partnership Renewal ↗

November 27, 2024

Via Benzinga

Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030 ↗

November 26, 2024

According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.

Via Benzinga

Topics Cannabis

80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need? ↗

November 22, 2024

According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x.

Via Benzinga

Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners & Losers ↗

November 21, 2024

BDSA's October 2024 data highlights Maryland as the fastest-growing state for cannabis sales, with a year-to-date increase of 57.8%.

Via Benzinga

Topics Cannabis

420 with CNW — Trump’s Pick for AG Triggers Hope Within the Marijuana Community

November 21, 2024

Via CannabisNewsWire

Topics Cannabis Government

Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee ↗

November 21, 2024

The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.

Via Benzinga

Topics Cannabis ETFs Government

Curaleaf Secures First Marijuana Research License In Massachusetts ↗

November 18, 2024

Via Benzinga

Topics Cannabis

Can Trump's Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning ↗

November 18, 2024

The post-election landscape raises uncertainty for cannabis MSOs, with investors hoping for potential relief from the new administration.

Via Benzinga

Topics Cannabis Government

Trump Wants Matt Gaetz Confirmed '100%,' So Does The Cannabis Industry ↗

November 18, 2024

Trump's nomination of Gaetz for Attorney General has stirred controversy and sparked doubts due to his past controversies and inconsistent stance on cannabis.

Via Benzinga

Topics Cannabis Government

Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores ↗

November 15, 2024

RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), opened RISE Dispensary Orlando on Good Homes Road on Friday, Nov. 8. Located at 725 Good...

Via Benzinga

Topics Cannabis

Flora Growth Quarterly Revenue Falls 28% YoY As Expenses Rise ↗

November 15, 2024

Via Benzinga

Missouri’s Booming Marijuana Industry Eclipses Other State Markets

November 14, 2024

Via CannabisNewsWire

Topics Cannabis

Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General ↗

November 13, 2024

Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment.

Via Benzinga

Topics Cannabis Government

Cannabis Stocks Plunged After Florida Legalization Failed: Rational Reaction Or Market Overreach? ↗

November 08, 2024

Florida's failed adult-use cannabis vote led to a $2.6B loss in market cap. Was the market reaction justified? Earnings data adds uncertainty.

Via Benzinga

Topics Cannabis

Hemp Market Surge: How New Regulations Could Impact Growth ↗

November 08, 2024

Hemp industry regulatory changes in 2024 may impact delta-8 THC sales, spark market shifts, and intensify hemp vs. marijuana sector conflicts.

Via Benzinga

Topics Cannabis

Curaleaf Q3 Report: 3% Increase In EBITDA And 9% Decrease In Net Loss ↗

November 08, 2024

Curaleaf Holdings, Inc. reported its financial and operating results for the third quarter.

Via Talk Markets

420 with CNW — Gallup Survey Finds US Bipartisan Majority Support for Cannabis Legalization Stable

November 07, 2024

Via CannabisNewsWire

Topics Cannabis

Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close ↗

November 06, 2024

Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today.

Via Benzinga

Topics Cannabis Government

Curaleaf Q3 Results: Strong Margins But $44M Loss, What's Next For Investors? ↗

November 06, 2024

The company reported a net loss of $44 million, equivalent to $0.07 per share, with adjusted EBITDA at $75.3 million.

Via Benzinga

Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty ↗

November 06, 2024

Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth.

Via Benzinga

Topics Cannabis

< Previous 1 2 3 4 5 6 7 8 9

...

56 57 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.